• Exchange: OTC US
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Abattis Bioceuticals Corp

+ Add to Watchlist

ATTBF:US

0.1309 USD 0.0001 0.08%

As of 17:20:23 ET on 12/17/2014.

Snapshot for Abattis Bioceuticals Corp (ATTBF)

Open: 0.1300 Day's Range: 0.1300 - 0.1400 Volume: 179,614
Previous Close: 0.1310 52wk Range: 0.0001 - 2.7800 1-Yr Rtn: +357.29%

Stock Chart for ATTBF

No chart data available.
  • ATTBF:US 0.1309
  • 1D
  • 1M
  • 1Y
0.1310
Interactive ATTBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATTBF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 6.23
Shares Outstanding (M) 47.62
30 Day Average Volume 282,480
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 12/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATTBF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ATTBF

Abattis Biologix Corporation researches, develops and manufactures natural botanical formulations to prevent or treat influenza strains in birds, humans and other mammals.

Michael Withrow "Mike"Chairman/President/CEOJaouad FichtaliChief Technology Officer
Terence Fealey "Tim"Advisor:Global Product Dev
More Company Profile & Key Executives for ATTBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil